Clinical Trial Update: Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update on DPP-4 inhibition and its effect on the entero-insular axis in diabetes; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Michael A. Nauck | Conditions: Diabetes | Phase 2, Phase 3 | Status: COMPLETED